WSPN Achieves ISO/IEC 27001:2022 Certification, Reinforcing Its Commitment to World-Class Information Security
TORTOLA, British Virgin Islands, Dec. 11, 2025 /PRNewswire/ — Worldwide Stablecoin Payment Network (WSPN), a leading provider of next-generation stablecoin... Read more.
ZIEA Unveils World’s First AI Desktop Calendar Designed to Reclaim Your Focus in an Age of Distraction
SAN FRANCISCO, Dec. 11, 2025 /PRNewswire/ — ZIEA, an innovator in personal productivity hardware, today announced the upcoming launch of the ZIEA AI Calendar,... Read more.
Cadonilimab (PD-1/CTLA-4) Receives FDA Clearance for Global Phase III First-Line Gastric Cancer Trial Versus Nivolumab
HONG KONG, Dec. 11, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) announced FDA approval to initiate COMPASSION-37/AK104-311... Read more.
StreamKey to Represent SJE Rhombus Across Key Midwest and Appalachian Markets
Collaboration brings responsive, on‑the‑ground support to IN, KY, OH, WV, and Western PA. DETROIT LAKES, Minn., Dec. 11, 2025 /PRNewswire/ — SJE Rhombus... Read more.
CAE awarded contract to deliver Australia’s Future Air Mission Training System
SYDNEY, Dec. 11, 2025 /PRNewswire/ – (NYSE: CAE) (TSX: CAE) – CAE today announced that it has secured a landmark contract with the Commonwealth of Australia... Read more.
RealD and CJ 4DPLEX Partner to Integrate RealD 3D into SCREENX, Creating a Next-Level Immersive Cinema Experience for Movie Theaters Around the World
Regal Cinemas commits to upgrade 52 sites in time for Disney/Lightstorm’s Avatar:Fire and Ash, in theaters December 19th LOUISVILLE, Colo. and BURBANK, Calif.,... Read more.
SEMIFIVE Secures AI Semiconductor Design Projects in Japan, Accelerating Global Expansion with New Local Subsidiary
– Demonstrates end-to-end expertise in high-performance custom chip design for AI and HPC– Establishes a subsidiary in Japan to strengthen global reach... Read more.
Mazdutide Demonstrates Significant Weight Loss and Metabolic Benefits in Phase 1b Clinical Trial in Chinese Adolescents with Obesity
After 12 weeks of treatment, the 4 mg and 6 mg mazdutide groups achieved reductions in BMI from baseline of 8.78% and 10.99%, respectively, with corresponding body... Read more.
Hart, Travers & Associates, Inc. to Represent SJE Rhombus in Northern Illinois and Northwest Indiana
Collaboration brings a customer-first approach to serving customers across the territory. DETROIT LAKES, Minn., Dec. 11, 2025 /PRNewswire/ — SJE Rhombus is... Read more.
FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing* First and Only CD19-Targeted B Cell Therapy Approved in anti-AChR and anti-MuSK... Read more.